Rare diseases
Investigational molecules
Locations
80 avenue Augustin Fliche, 34295 Montpellier cedex 5, 34295 Montpellier, France
Hôpital Guy de Chauliac in Montpellier, France specialises in clinical trials of conditions such as Cytomegalovirus immunisation, Mucopolysaccharidosis II, and other specialisations. This site conducts important research.
The medical center is at the forefront of research in Mucopolysaccharidosis Type II, commonly known as Hunter Syndrome. This rare genetic disorder is characterized by a deficiency in the enzyme iduronate-2-sulfatase, leading to the accumulation of glycosaminoglycans in the body.
Through its pioneering research, the center is evaluating the efficacy and safety of JR-141, a promising treatment aimed at addressing both CNS and somatic symptoms in patients with MPS II. This research is crucial in advancing therapeutic options and improving the quality of life for those affected by this challenging condition.
More sites in MontpellierFrance
Clinical trials registered at this site – none is enrolling right now.
FranceFranceGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
